Summit Trail Advisors, LLC Bio N Tech Se Transaction History

Summit Trail Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $117,286 - $215,388	-929 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$216.64 - $362.52 $27,946 - $46,765	129 Added 16.13%	929 $239,000
Q3 2021 Nov 16, 2021	SELL	$205.93 - $447.23 $51,482 - $111,807	-250 Reduced 23.81%	800 $218,000
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $118,986 - $253,564	1,050 New	1,050 $235,000

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.2B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.